China · Delayed Price · Currency is CNY Aurisco Pharmaceutical Statistics
Total Valuation
SHA:605116 has a market cap or net worth of CNY 12.59 billion. The enterprise value is 12.54 billion.
| Market Cap | 12.59B |
| Enterprise Value | 12.54B |
Important Dates
The next estimated earnings date is Friday, April 17, 2026.
| Earnings Date | Apr 17, 2026 |
| Ex-Dividend Date | Jun 20, 2025 |
Share Statistics
SHA:605116 has 406.18 million shares outstanding. The number of shares has decreased by -3.69% in one year.
| Current Share Class | 406.18M |
| Shares Outstanding | 406.18M |
| Shares Change (YoY) | -3.69% |
| Shares Change (QoQ) | -0.68% |
| Owned by Insiders (%) | 74.98% |
| Owned by Institutions (%) | 2.53% |
| Float | 88.30M |
Valuation Ratios
The trailing PE ratio is 29.15 and the forward PE ratio is 27.67.
| PE Ratio | 29.15 |
| Forward PE | 27.67 |
| PS Ratio | 7.75 |
| PB Ratio | 4.95 |
| P/TBV Ratio | 5.28 |
| P/FCF Ratio | 324.03 |
| P/OCF Ratio | 32.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.62, with an EV/FCF ratio of 322.75.
| EV / Earnings | 29.53 |
| EV / Sales | 7.72 |
| EV / EBITDA | 21.62 |
| EV / EBIT | 25.72 |
| EV / FCF | 322.75 |
Financial Position
The company has a current ratio of 4.30, with a Debt / Equity ratio of 0.39.
| Current Ratio | 4.30 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 1.71 |
| Debt / FCF | 25.51 |
| Interest Coverage | 13.88 |
Financial Efficiency
Return on equity (ROE) is 17.65% and return on invested capital (ROIC) is 9.14%.
| Return on Equity (ROE) | 17.65% |
| Return on Assets (ROA) | 7.85% |
| Return on Invested Capital (ROIC) | 9.14% |
| Return on Capital Employed (ROCE) | 13.60% |
| Revenue Per Employee | 910,578 |
| Profits Per Employee | 237,970 |
| Employee Count | 1,784 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.10 |
Taxes
In the past 12 months, SHA:605116 has paid 62.35 million in taxes.
| Income Tax | 62.35M |
| Effective Tax Rate | 12.81% |
Stock Price Statistics
The stock price has increased by +53.52% in the last 52 weeks. The beta is -0.10, so SHA:605116's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | +53.52% |
| 50-Day Moving Average | 24.73 |
| 200-Day Moving Average | 22.82 |
| Relative Strength Index (RSI) | 66.59 |
| Average Volume (20 Days) | 7,323,465 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:605116 had revenue of CNY 1.62 billion and earned 424.54 million in profits. Earnings per share was 1.06.
| Revenue | 1.62B |
| Gross Profit | 964.36M |
| Operating Income | 487.42M |
| Pretax Income | 486.89M |
| Net Income | 424.54M |
| EBITDA | 574.18M |
| EBIT | 487.42M |
| Earnings Per Share (EPS) | 1.06 |
Balance Sheet
The company has 1.04 billion in cash and 991.16 million in debt, with a net cash position of 49.67 million or 0.12 per share.
| Cash & Cash Equivalents | 1.04B |
| Total Debt | 991.16M |
| Net Cash | 49.67M |
| Net Cash Per Share | 0.12 |
| Equity (Book Value) | 2.54B |
| Book Value Per Share | 6.26 |
| Working Capital | 1.60B |
Cash Flow
In the last 12 months, operating cash flow was 382.39 million and capital expenditures -343.54 million, giving a free cash flow of 38.85 million.
| Operating Cash Flow | 382.39M |
| Capital Expenditures | -343.54M |
| Free Cash Flow | 38.85M |
| FCF Per Share | 0.10 |
Margins
Gross margin is 59.36%, with operating and profit margins of 30.00% and 26.13%.
| Gross Margin | 59.36% |
| Operating Margin | 30.00% |
| Pretax Margin | 29.97% |
| Profit Margin | 26.13% |
| EBITDA Margin | 35.35% |
| EBIT Margin | 30.00% |
| FCF Margin | 2.39% |
Dividends & Yields
This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 0.93%.
| Dividend Per Share | 0.29 |
| Dividend Yield | 0.93% |
| Dividend Growth (YoY) | 31.82% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 29.85% |
| Buyback Yield | 3.69% |
| Shareholder Yield | 4.61% |
| Earnings Yield | 3.37% |
| FCF Yield | 0.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:605116 has an Altman Z-Score of 5.23 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.23 |
| Piotroski F-Score | 5 |